The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2018

Filed:

Dec. 21, 2016
Applicant:

Domantis Limited, Brentford, Middlesex, GB;

Inventors:

Laurent Jespers, Cambridge, GB;

Malgorzata Pupecka-Swider, Cambridge, GB;

Carolyn Enever, Cambridge, GB;

Ian Tomlinson, Cambridge, GB;

Assignee:

Domantis Limited, Brentford, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 9/16 (2006.01); A61K 9/00 (2006.01); C07K 16/00 (2006.01); C07K 16/22 (2006.01); A61M 11/00 (2006.01); A61M 15/08 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 9/007 (2013.01); A61K 9/1623 (2013.01); A61K 9/1641 (2013.01); A61K 39/3955 (2013.01); A61M 11/005 (2013.01); A61M 15/08 (2013.01); C07K 16/005 (2013.01); C07K 16/22 (2013.01); C07K 16/2866 (2013.01); C07K 2317/569 (2013.01); C07K 2317/64 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

The invention relates to anti-TNFR1 polypeptides and antibody single variable domains (dAbs) that are resistant to degradation by a protease, as well as antagonists comprising these. The polypeptides, dAbs and antagonists are useful for as therapeutics and/or prophylactics that are likely to encounter proteases when administered to a patient, for example for pulmonary administration, oral administration, delivery to the lung and delivery to the GI tract of a patient, as well as for treating inflammatory disease, such as arthritis or COPD.


Find Patent Forward Citations

Loading…